Skip to main content

Psoriatic Arthritis

Quiz
04/28/2026
Rebecca Mashaw
Do you know which patients with psoriasis are most at risk of progression to psoriatic arthritis? Take our quick quiz to find out!
Do you know which patients with psoriasis are most at risk of progression to psoriatic arthritis? Take our quick quiz to find out!
Do you know which patients with...
04/28/2026
Rheumatology & Arthritis
News
08/15/2024
Rebecca Mashaw
Coverage changes omitted self-injected therapies from Part B, but new negotiated price will reduce costs 66-67%.
Coverage changes omitted self-injected therapies from Part B, but new negotiated price will reduce costs 66-67%.
Coverage changes omitted...
08/15/2024
Rheumatology & Arthritis
News
03/04/2024
Priyam Vora
Researchers estimated the short-term risks and long-term incidence rates of infection and malignancy with IL-17 or IL-23 inhibitors among patients with psoriasis and psoriatic arthritis.
Researchers estimated the short-term risks and long-term incidence rates of infection and malignancy with IL-17 or IL-23 inhibitors among patients with psoriasis and psoriatic arthritis.
Researchers estimated the...
03/04/2024
Rheumatology & Arthritis
Quiz
02/22/2024
Priyam Vora
Researchers developed the Psoriatic Arthritis Risk Estimation Tool (PRESTO) to predict the 1- and 5-year risk of developing psoriatic arthritis in patients with psoriasis. Take our quiz to test your knowledge on the subject!
Researchers developed the Psoriatic Arthritis Risk Estimation Tool (PRESTO) to predict the 1- and 5-year risk of developing psoriatic arthritis in patients with psoriasis. Take our quiz to test your knowledge on the subject!
Researchers developed the...
02/22/2024
Rheumatology & Arthritis
News
01/30/2024
Priyam Vora
A recent Swedish cohort study shed light on disparities observed in relation to sex, age, and disease duration, which significantly influence the mortality risk among patients with psoriatic arthritis.
A recent Swedish cohort study shed light on disparities observed in relation to sex, age, and disease duration, which significantly influence the mortality risk among patients with psoriatic arthritis.
A recent Swedish cohort study...
01/30/2024
Rheumatology & Arthritis
News
01/29/2024
Priyam Vora
The findings suggest the interest of rheumatologists to use ultrasound in the management of psoriatic arthritis.
The findings suggest the interest of rheumatologists to use ultrasound in the management of psoriatic arthritis.
The findings suggest the...
01/29/2024
Rheumatology & Arthritis
Conference Coverage
01/03/2024
Priyam Vora
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic arthritis and axial spondyloarthritis may be able to safely taper tumor necrosis factor inhibitors using a treat-to-target approach, new research indicates.
Patients with psoriatic...
01/03/2024
Rheumatology & Arthritis
Conference Coverage
01/02/2024
Dr Haberman characterized a cohort of patients with psoriatic arthritis to evaluate how race, ethnicity, and sex may inform features of clinical presentation, comorbidities, disease course and outcomes.
Dr Haberman characterized a cohort of patients with psoriatic arthritis to evaluate how race, ethnicity, and sex may inform features of clinical presentation, comorbidities, disease course and outcomes.
Dr Haberman characterized a...
01/02/2024
Rheumatology & Arthritis
News
12/06/2023
Priyam Vora
Investigators compared the characteristics and disease burden of PsA between early-onset and late-onset groups. What did they find?
Investigators compared the characteristics and disease burden of PsA between early-onset and late-onset groups. What did they find?
Investigators compared the...
12/06/2023
Rheumatology & Arthritis
Conference Coverage
12/05/2023
Priyam Vora
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been studied for rheumatoid arthritis and ulcerative colitis. What’s the role of JAKi in the treatment of psoriatic arthritis?
JAK inhibitors (JAKi) have been...
12/05/2023
Rheumatology & Arthritis